Francesco ChiaramonteFrancesco Chiaramonte
Home   >   GPT-3 Alzheimer

Drexel University researchers have found that OpenAI’s GPT-3 can detect the first indications of Alzheimer’s disease using spontaneous speech with an accuracy of 80%. Changes in speech patterns are a key diagnostic for Alzheimer’s disease, an irreversible brain condition.

The research demonstrates that GPT-3’s text embedding can distinguish between people with Alzheimer’s disease and healthy people and can even predict cognitive test results from only speech data. This AI-driven speech analysis performs better than custom models and conventional techniques. These results show the promise of employing AI techniques for early dementia diagnosis, enabling personalised interventions, and improving the quality of life for those who are affected.

User objects:

– Medical researchers

– Neurologists

– Geriatricians

– Speech therapists

– Cognitive specialists

– Dementia caregivers

– Alzheimer’s disease specialists

>>> Use Chat GPT Demo with OpenAI’s equivalent smart bot experience




Francesco Chiaramonte

Francesco Chiaramonte is renowned for over 10 years of experience, from machine learning to AI entrepreneurship. He shares knowledge and is committed to advancing artificial intelligence, hoping that AI will drive societal progress.